Breaking News Instant updates and real-time market news.

SNSS

Sunesis

$0.90 /

-0.055 (-5.79%)

13:28
06/16/19
06/16
13:28
06/16/19
13:28

Sunesis announces preliminary data from Phase 1b/2 trial of Vecabrutinib

Sunesis Pharmaceuticals announced the presentation of results from the company's Phase 1b/2 clinical trial of its non-covalent BTK inhibitor vecabrutinib in adults with relapsed/refractory chronic lymphocytic leukemia and other B-cell malignancies. Preliminary data reported were available from 23 patients treated in the trial thus far. These included 19 CLL patients, two mantle cell lymphoma patients, and two Waldenstrom Macroglobulinemia patients. Patients had received an average of 4 lines of prior therapy, and all patients had progressed on prior BTKi therapy. 61% of CLL patients enrolled had a BTK C481 mutation as of the data cutoff for the poster. Preliminary data on treatment-emergent adverse events were available for 20 patients. The most common TEAEs of any grade were anemia and neutropenia and night sweats, with 5 drug-related Grade 3 adverse events occurring in 3 patients, all in cohort 2. In total, there were 8 serious adverse events in six patients, none of which were considered drug-related. Stable disease was seen in 4 CLL patients, 3 of whom had BTK C481S mutations. Two of these patients, both with BTK C481S mutations, showed decreases of 16% and 47% in index lesions at first assessment by CT scans. The patient with the 47% decrease was one of two evaluable post-venetoclax patients with the BTK C481S mutation. A patient with WM experienced clinical benefit with improvement in B-symptoms but no impact on immunoglobulin M. One patient in cohort 3 continues on treatment in cycle 6. The pharmacokinetic profile of vecabrutinib showed sustained exposure over the dosing interval, with median steady-state trough concentrations increasing with dose. Preliminary data showed near doubling of trough concentrations between doses of 50 mg and 100 mg. Based on the results of the Phase 1A study in healthy subjects, trough levels of greater than1,000 ng/mL are expected to be required for consistent BTK inhibition and greater clinical activity. This is likely achievable with doses higher than 100 mg BID. Vecabrutinib inhibition of BTK phosphorylation was rapid and sustained in patients who had adequate baseline signal for analysis. Decreases in serum concentrations of key cytokines associated with B-cell malignancies, CCL2, CCL3, and CCL4, were observed in most evaluable patients, consistent with inhibition of BTK signaling.

  • 24

    Jun

  • 25

    Jun

SNSS Sunesis
$0.90 /

-0.055 (-5.79%)

12/20/18 H.C. Wainwright
Sunesis initiated with a Neutral at H.C. Wainwright

TODAY'S FREE FLY STORIES

Earnings
The ODP Corporation reports Q2 adjusted EPS (7c), consensus 8c » 06:52
08/05/20
08/05
06:52
08/05/20
06:52
ODP

The ODP Corporation

$20.93 /

-0.37 (-1.74%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ODP The ODP Corporation
$20.93 /

-0.37 (-1.74%)

ODP The ODP Corporation
$20.93 /

-0.37 (-1.74%)

04/30/20 Sidoti
Office Depot initiated with a Buy at Sidoti
08/20/19 BofA/Merrill
Office Depot price target lowered to $1.20 from $2 at BofA/Merrill
ODP The ODP Corporation
$20.93 /

-0.37 (-1.74%)

ODP The ODP Corporation
$20.93 /

-0.37 (-1.74%)

ODP The ODP Corporation
$20.93 /

-0.37 (-1.74%)

Earnings
Thomson Reuters sees Q3 revenue growth 1%-2%, consensus $2.91B » 06:52
08/05/20
08/05
06:52
08/05/20
06:52
TRI

Thomson Reuters

$71.02 /

+0.66 (+0.94%)

Sees Q3 effective tax…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRI Thomson Reuters
$71.02 /

+0.66 (+0.94%)

TRI Thomson Reuters
$71.02 /

+0.66 (+0.94%)

05/06/20
Fly Intel: Top five analyst downgrades
05/06/20
Fly Intel: Top five analyst upgrades
05/06/20 TD Securities
TD downgrades Thomson Reuters on valuation following BMO upgrade
05/06/20 TD Securities
Thomson Reuters downgraded to Hold from Buy at TD Securities
TRI Thomson Reuters
$71.02 /

+0.66 (+0.94%)

TRI Thomson Reuters
$71.02 /

+0.66 (+0.94%)

Upgrade
R1 RCM upgraded to Outperform from Market Perform at SVB Leerink » 06:52
08/05/20
08/05
06:52
08/05/20
06:52
RCM

R1 RCM

$15.09 /

+0.955 (+6.76%)

SVB Leerink analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RCM R1 RCM
$15.09 /

+0.955 (+6.76%)

RCM R1 RCM
$15.09 /

+0.955 (+6.76%)

04/20/20 RBC Capital
R1 RCM initiated with an Outperform at RBC Capital
04/13/20 SVB Leerink
R1 RCM initiated with a Market Perform at SVB Leerink
03/26/20 Cowen
Cowen sees three healthcare IT names poised for rebound
01/21/20 Cantor Fitzgerald
R1 RCM price target raised to $17 from $15 at Cantor Fitzgerald
RCM R1 RCM
$15.09 /

+0.955 (+6.76%)

RCM R1 RCM
$15.09 /

+0.955 (+6.76%)

Downgrade
AON Corp. downgraded to Underperform from Market Perform at Raymond James » 06:51
08/05/20
08/05
06:51
08/05/20
06:51
AOC

AON Corp.

$0.00 /

+ (+0.00%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
BorgWarner up 1.4% after reporting Q2 results » 06:51
08/05/20
08/05
06:51
08/05/20
06:51
BWA

BorgWarner

$37.15 /

+0.22 (+0.60%)

Shares of BorgWarner are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

06/19/20 JPMorgan
BorgWarner price target raised to $40 from $35 at JPMorgan
05/28/20 Wolfe Research
BorgWarner upgraded to Outperform from Peer Perform at Wolfe Research
04/13/20 KeyBanc
BorgWarner upgraded to Overweight from Sector Weight at KeyBanc
03/30/20
Fly Intel: Top five analyst downgrades
BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

Hot Stocks
UnitedHealth authorizes cash dividend of $1.25 per share » 06:51
08/05/20
08/05
06:51
08/05/20
06:51
UNH

UnitedHealth

$304.37 /

+0.595 (+0.20%)

The UnitedHealth Group…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UNH UnitedHealth
$304.37 /

+0.595 (+0.20%)

UNH UnitedHealth
$304.37 /

+0.595 (+0.20%)

07/31/20 Guggenheim
Guggenheim upgrades Tandem Diabetes to Buy, says tailwinds not fully baked in
07/16/20 SVB Leerink
UnitedHealth price target raised to $370 from $360 at SVB Leerink
07/16/20 Oppenheimer
UnitedHealth price target raised to $353 from $343 at Oppenheimer
07/16/20 Deutsche Bank
UnitedHealth price target raised to $312 from $293 at Deutsche Bank
UNH UnitedHealth
$304.37 /

+0.595 (+0.20%)

UNH UnitedHealth
$304.37 /

+0.595 (+0.20%)

UNH UnitedHealth
$304.37 /

+0.595 (+0.20%)

UNH UnitedHealth
$304.37 /

+0.595 (+0.20%)

Earnings
Thomson Reuters reports Q2 adj. EPS 44c, consensus 58c » 06:50
08/05/20
08/05
06:50
08/05/20
06:50
TRI

Thomson Reuters

$71.02 /

+0.66 (+0.94%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TRI Thomson Reuters
$71.02 /

+0.66 (+0.94%)

TRI Thomson Reuters
$71.02 /

+0.66 (+0.94%)

05/06/20
Fly Intel: Top five analyst downgrades
05/06/20
Fly Intel: Top five analyst upgrades
05/06/20 TD Securities
TD downgrades Thomson Reuters on valuation following BMO upgrade
05/06/20 TD Securities
Thomson Reuters downgraded to Hold from Buy at TD Securities
TRI Thomson Reuters
$71.02 /

+0.66 (+0.94%)

TRI Thomson Reuters
$71.02 /

+0.66 (+0.94%)

Hot Stocks
BorgWarner reports Q2 Drivetrain segment net sales $607M vs. $998M last year » 06:50
08/05/20
08/05
06:50
08/05/20
06:50
BWA

BorgWarner

$37.15 /

+0.22 (+0.60%)

BorgWarner said in its Q2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

06/19/20 JPMorgan
BorgWarner price target raised to $40 from $35 at JPMorgan
05/28/20 Wolfe Research
BorgWarner upgraded to Outperform from Peer Perform at Wolfe Research
04/13/20 KeyBanc
BorgWarner upgraded to Overweight from Sector Weight at KeyBanc
03/30/20
Fly Intel: Top five analyst downgrades
BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

Recommendations
Twilio price target raised to $315 from $260 at Mizuho » 06:50
08/05/20
08/05
06:50
08/05/20
06:50
TWLO

Twilio

$283.39 /

-2.995 (-1.05%)

Mizuho analyst Siti…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TWLO Twilio
$283.39 /

-2.995 (-1.05%)

TWLO Twilio
$283.39 /

-2.995 (-1.05%)

07/27/20 Rosenblatt
Vonage initiated with a Neutral at Rosenblatt
07/24/20 Wolfe Research
Twilio initiated with an Outperform at Wolfe Research
07/20/20 Morgan Stanley
Twilio price target raised to $240 from $160 at Morgan Stanley
07/17/20 Cowen
Twilio price target raised to $260 from $230 at Cowen
TWLO Twilio
$283.39 /

-2.995 (-1.05%)

TWLO Twilio
$283.39 /

-2.995 (-1.05%)

TWLO Twilio
$283.39 /

-2.995 (-1.05%)

TWLO Twilio
$283.39 /

-2.995 (-1.05%)

Earnings
Store Capital reports Q2 adjusted FFO 44c, consensus 44c » 06:49
08/05/20
08/05
06:49
08/05/20
06:49
STOR

Store Capital

$24.45 /

+1 (+4.26%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STOR Store Capital
$24.45 /

+1 (+4.26%)

STOR Store Capital
$24.45 /

+1 (+4.26%)

08/03/20
Fly Intel: Top five analyst initiations
08/03/20 Evercore ISI
Store Capital initiated with an Outperform at Evercore ISI
06/29/20 Jefferies
Store Capital initiated with a Buy at Jefferies
06/18/20 Wells Fargo
Store Capital price target raised to $24 from $19 at Wells Fargo
STOR Store Capital
$24.45 /

+1 (+4.26%)

STOR Store Capital
$24.45 /

+1 (+4.26%)

STOR Store Capital
$24.45 /

+1 (+4.26%)

Hot Stocks
BorgWarner reports Q2 Engine segment net sales $826M vs. $1.57B last year » 06:49
08/05/20
08/05
06:49
08/05/20
06:49
BWA

BorgWarner

$37.15 /

+0.22 (+0.60%)

BorgWarner said in its Q2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

06/19/20 JPMorgan
BorgWarner price target raised to $40 from $35 at JPMorgan
05/28/20 Wolfe Research
BorgWarner upgraded to Outperform from Peer Perform at Wolfe Research
04/13/20 KeyBanc
BorgWarner upgraded to Overweight from Sector Weight at KeyBanc
03/30/20
Fly Intel: Top five analyst downgrades
BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

Hot Stocks
Humana backs 2020 group Medicare Advantage membership growth outlook » 06:48
08/05/20
08/05
06:48
08/05/20
06:48
HUM

Humana

$391.19 /

-3.69 (-0.93%)

The company is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

07/27/20 BofA
Accolade initiated with a Buy at BofA
07/23/20 Evercore ISI
Evercore ISI says Humana pact relates to FIT testing, not Exact's Cologuard
07/23/20 Evercore ISI
Humana plans could boost Exact's growth as much as 12%, says Evercore ISI
07/01/20 SVB Leerink
Humana reinstated with an Outperform at SVB Leerink
HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

HUM Humana
$391.19 /

-3.69 (-0.93%)

Recommendations
LivePerson price target raised to $65 from $45 at Mizuho » 06:48
08/05/20
08/05
06:48
08/05/20
06:48
LPSN

LivePerson

$46.25 /

+0.95 (+2.10%)

Mizuho analyst Siti…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LPSN LivePerson
$46.25 /

+0.95 (+2.10%)

LPSN LivePerson
$46.25 /

+0.95 (+2.10%)

05:03 Today Jefferies
LivePerson price target raised to $55 from $33 at Jefferies
07/29/20 B. Riley FBR
LivePerson price target raised to $49 from $43 at B. Riley FBR
07/06/20 Benchmark
LivePerson price target raised to $50 from $43 at Benchmark
07/01/20 KeyBanc
LivePerson price target raised to $48 from $38 at KeyBanc
LPSN LivePerson
$46.25 /

+0.95 (+2.10%)

LPSN LivePerson
$46.25 /

+0.95 (+2.10%)

LPSN LivePerson
$46.25 /

+0.95 (+2.10%)

LPSN LivePerson
$46.25 /

+0.95 (+2.10%)

Earnings
BorgWarner sees FY20 revenue $8B-$8.4B, consensus $8.16B » 06:48
08/05/20
08/05
06:48
08/05/20
06:48
BWA

BorgWarner

$37.15 /

+0.22 (+0.60%)

BorgWarner said in its Q2…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

06/19/20 JPMorgan
BorgWarner price target raised to $40 from $35 at JPMorgan
05/28/20 Wolfe Research
BorgWarner upgraded to Outperform from Peer Perform at Wolfe Research
04/13/20 KeyBanc
BorgWarner upgraded to Overweight from Sector Weight at KeyBanc
03/30/20
Fly Intel: Top five analyst downgrades
BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

Downgrade
BP downgraded to In Line after dividend reset at Evercore ISI » 06:47
08/05/20
08/05
06:47
08/05/20
06:47
BP

BP

$23.73 /

+1.64 (+7.42%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BP BP
$23.73 /

+1.64 (+7.42%)

BP BP
$23.73 /

+1.64 (+7.42%)

06:43 Today Evercore ISI
BP downgraded to In Line from Outperform at Evercore ISI
05:25 Today Societe Generale
BP upgraded to Buy from Hold at Societe Generale
07/16/20 Jefferies
BP upgraded to Buy from Hold at Jefferies
07/15/20 JPMorgan
BP price target raised to 425 GBp from 400 GBp at JPMorgan
BP BP
$23.73 /

+1.64 (+7.42%)

BP BP
$23.73 /

+1.64 (+7.42%)

BP BP
$23.73 /

+1.64 (+7.42%)

BP BP
$23.73 /

+1.64 (+7.42%)

Earnings
Parsons backs FY20 revenue view $3.95B-$4.05B, consensus $4.02B  06:47
08/05/20
08/05
06:47
08/05/20
06:47
PSN

Parsons

$35.46 /

-0.28 (-0.78%)

 
ShowHide Related Items >><<
PSN Parsons
$35.46 /

-0.28 (-0.78%)

PSN Parsons
$35.46 /

-0.28 (-0.78%)

05/05/20 Wells Fargo
Parsons price target raised to $39 from $33 at Wells Fargo
04/15/20 Benchmark
Parsons initiated with a Buy at Benchmark
04/02/20 Wells Fargo
Parsons price target lowered to $33 from $42 at Wells Fargo
03/30/20 William Blair
Parsons initiated with an Outperform at William Blair
PSN Parsons
$35.46 /

-0.28 (-0.78%)

PSN Parsons
$35.46 /

-0.28 (-0.78%)

Earnings
Athene Holding reports Q2 adjusted EPS $2.49, consensus $1.71 » 06:47
08/05/20
08/05
06:47
08/05/20
06:47
ATH

Athene Holding

$32.60 /

-0.29 (-0.88%)

Adjusted book value per…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATH Athene Holding
$32.60 /

-0.29 (-0.88%)

ATH Athene Holding
$32.60 /

-0.29 (-0.88%)

06/22/20 BMO Capital
Athene Holding price target raised to $66 from $60 at BMO Capital
05/12/20 SunTrust
Athene Holding price target lowered to $45 from $61 at SunTrust
04/27/20 Credit Suisse
Athene Holding price target lowered to $46 from $59 at Credit Suisse
03/20/20 RBC Capital
RBC Capital sees some time before Life Insurance returns to 'normal'
ATH Athene Holding
$32.60 /

-0.29 (-0.88%)

Earnings
BorgWarner reports Q2 GAAP EPS (47c), consensus (45c) » 06:47
08/05/20
08/05
06:47
08/05/20
06:47
BWA

BorgWarner

$37.15 /

+0.22 (+0.60%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

06/19/20 JPMorgan
BorgWarner price target raised to $40 from $35 at JPMorgan
05/28/20 Wolfe Research
BorgWarner upgraded to Outperform from Peer Perform at Wolfe Research
04/13/20 KeyBanc
BorgWarner upgraded to Overweight from Sector Weight at KeyBanc
03/30/20
Fly Intel: Top five analyst downgrades
BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

BWA BorgWarner
$37.15 /

+0.22 (+0.60%)

Recommendations
Incyte price target raised to $95 from $79 at Mizuho » 06:46
08/05/20
08/05
06:46
08/05/20
06:46
INCY

Incyte

$99.93 /

-1.91 (-1.88%)

Mizuho analyst Mara…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INCY Incyte
$99.93 /

-1.91 (-1.88%)

INCY Incyte
$99.93 /

-1.91 (-1.88%)

08/03/20 Deutsche Bank
MorphoSys FDA approval in line with expectations, says Deutsche Bank
08/03/20 Piper Sandler
Monjuvi U.S. launch a solid long-term contributor for Incyte, says Piper Sandler
07/23/20 Stifel
Incyte REACH3 'nice incremental surprise,' not narrative-changing, says Stifel
07/23/20 Piper Sandler
Piper says Incyte cements 'all-around win for Jakafi' with REACH3 results
INCY Incyte
$99.93 /

-1.91 (-1.88%)

INCY Incyte
$99.93 /

-1.91 (-1.88%)

INCY Incyte
$99.93 /

-1.91 (-1.88%)

Earnings
NOW Inc. reports Q2 adjusted EPS (16c), consensus (31c) » 06:46
08/05/20
08/05
06:46
08/05/20
06:46
DNOW

NOW Inc.

$8.52 /

+0.37 (+4.54%)

Reports Q2 revenue $370M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
DNOW NOW Inc.
$8.52 /

+0.37 (+4.54%)

DNOW NOW Inc.
$8.52 /

+0.37 (+4.54%)

07/10/20 Northland
NOW Inc. initiated with an Outperform at Northland
04/14/20 Cowen
NOW Inc. upgraded to Outperform at Cowen
04/14/20 Cowen
NOW Inc. upgraded to Outperform from Market Perform at Cowen
03/11/20 Stifel
MRC Global upgraded to Buy from Hold at Stifel
DNOW NOW Inc.
$8.52 /

+0.37 (+4.54%)

Earnings
Parsons reports Q2 adj. EPS 49c, consensus 29c » 06:46
08/05/20
08/05
06:46
08/05/20
06:46
PSN

Parsons

$35.46 /

-0.28 (-0.78%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PSN Parsons
$35.46 /

-0.28 (-0.78%)

PSN Parsons
$35.46 /

-0.28 (-0.78%)

05/05/20 Wells Fargo
Parsons price target raised to $39 from $33 at Wells Fargo
04/15/20 Benchmark
Parsons initiated with a Buy at Benchmark
04/02/20 Wells Fargo
Parsons price target lowered to $33 from $42 at Wells Fargo
03/30/20 William Blair
Parsons initiated with an Outperform at William Blair
PSN Parsons
$35.46 /

-0.28 (-0.78%)

PSN Parsons
$35.46 /

-0.28 (-0.78%)

Recommendations
NuStar Energy price target raised to $16 from $14 at Mizuho » 06:45
08/05/20
08/05
06:45
08/05/20
06:45
NS

NuStar Energy

$14.70 /

-0.115 (-0.78%)

Mizuho analyst Gabriel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NS NuStar Energy
$14.70 /

-0.115 (-0.78%)

NS NuStar Energy
$14.70 /

-0.115 (-0.78%)

04/06/20 Mizuho
NuStar Energy price target lowered to $14 from $33 at Mizuho
03/11/20 Citi
NuStar Energy upgraded to Buy from Neutral at Citi
02/05/20 UBS
NuStar Energy upgraded to Buy from Neutral at UBS
NS NuStar Energy
$14.70 /

-0.115 (-0.78%)

General news
Week of 7/31 MBA Mortgage Applications to be released at 07:00  06:45
08/05/20
08/05
06:45
08/05/20
06:45
 
Recommendations
HSBC bumps up Facebook target to $195, maintains Reduce rating » 06:44
08/05/20
08/05
06:44
08/05/20
06:44
FB

Facebook

$249.44 /

-2.3 (-0.91%)

HSBC analyst Nicolas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$249.44 /

-2.3 (-0.91%)

FB Facebook
$249.44 /

-2.3 (-0.91%)

08/04/20 Argus
Facebook price target raised to $300 from $270 at Argus
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
08/03/20 DA Davidson
Pinterest price target raised to $28 from $19 at DA Davidson
07/31/20
Facebook price target raised to $300 from $290 at JPMorgan
FB Facebook
$249.44 /

-2.3 (-0.91%)

FB Facebook
$249.44 /

-2.3 (-0.91%)

FB Facebook
$249.44 /

-2.3 (-0.91%)

FB Facebook
$249.44 /

-2.3 (-0.91%)

Downgrade
BP downgraded to In Line from Outperform at Evercore ISI » 06:43
08/05/20
08/05
06:43
08/05/20
06:43
BP

BP

$23.73 /

+1.64 (+7.42%)

Evercore ISI analyst Doug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BP BP
$23.73 /

+1.64 (+7.42%)

BP BP
$23.73 /

+1.64 (+7.42%)

05:25 Today Societe Generale
BP upgraded to Buy from Hold at Societe Generale
07/16/20 Jefferies
BP upgraded to Buy from Hold at Jefferies
07/15/20 JPMorgan
BP price target raised to 425 GBp from 400 GBp at JPMorgan
07/14/20 Credit Suisse
BP price target lowered to 350 GBp from 360 GBp at Credit Suisse
BP BP
$23.73 /

+1.64 (+7.42%)

BP BP
$23.73 /

+1.64 (+7.42%)

BP BP
$23.73 /

+1.64 (+7.42%)

BP BP
$23.73 /

+1.64 (+7.42%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.